General Information
Product name
Montelukast Sodium Chewable Tablets
CAS No.
151767-02-1
Manufacturer Name
Hetero labs limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc
Section 2
Hazard statements
This is a pharmaceutical product designed to be prescribed by a licensed health care professional. Should any person while using this product observe any adverse health effects, they should seek medical treatment. Because clinical trials are conducted under widely varying conditions, Adverse Effects adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice. In the following description of clinical trials experience, adverse reactions are listed regardless of causality assessment. The most common adverse reactions (incidence ≥5% and greater than placebo; listed in descending order of frequency) in controlled clinical trials were: upper respiratory infection, fever, headache, pharyngitis, cough, abdominal pain, diarrhea, otitis media, influenza, rhinorrhea, sinusitis, otitis. Contraindications Hypersensitivity to any component of this product.
